Unique Synthetic Strategy for Probing in Situ Lysosomal NO for Screening Neuroinflammatory Phenotypes against SARS-CoV-2 RNA in Phagocytotic Microglia
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.3c05981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Subrata Munan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Sensors and Therapeutics (MST) Research Laboratory, Department of Chemistry, School of Natural Sciences, Shiv Nadar Institution of Eminence…. Hauptthemen laut MEDLINE: Microglia, SARS-CoV-2, Lysosomes, Nitric Oxide. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Shiv Nadar Foundation, Science and Engineering Research Board, Shiv Nadar University.
Abstract (Originalsprache)
In the pathogenesis of microglia, brain immune cells promote nitrergic stress by overproducing nitric oxide (NO), leading to neuroinflammation. Furthermore, NO has been linked to COVID-19 progression, which has caused significant morbidity and mortality. SARS-CoV-2 infection activates inflammation by releasing excess NO and causing cell death in human microglial clone 3 (HMC3). In addition, NO regulates lysosomal functions and complex machinery to neutralize pathogens through phagocytosis. Therefore, developing lysosome-specific NO probes to monitor phagocytosis in microglia during the COVID-19 infection would be a significant study. Herein, a unique synthetic strategy was adopted to develop a NO selective fluorescent probe, PDM-NO, which can discriminate activated microglia from their resting state. The nonfluorescent PDM-NO exhibits a turn-on response toward NO only at lysosomal pH (4.5-5.5). Quantum chemical calculations (DFT/TD-DFT/PCM) and photophysical study revealed that the photoinduced electron transfer (PET) process is pivotal in tuning optical properties. PDM-NO demonstrated good biocompatibility and lysosomal specificity in activated HMC3 cells. Moreover, it can effectively map the dynamics of lysosomal NO against SARS-CoV-2 RNA-induced neuroinflammation in HMC3. Thus, PDM-NO is a potential fluorescent marker for detecting RNA virus infection and monitoring phagocytosis in HMC3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Sensors and Therapeutics (MST) Research Laboratory, Department of Chemistry, School of Natural Sciences, Shiv Nadar Institution of Eminence Deemed to be University (SNIoE), Delhi NCR, NH 91, Tehsil Dadri, Grea…
- Department of Life Sciences, School of Natural Sciences, Shiv Nadar Institution of Eminence Deemed to be University (SNIoE), Delhi NCR, NH 91, Tehsil Dadri, Greater Noida, Uttar Pradesh 201314, India.
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India.
ORCID-Profile: Subrata Munan, Animesh Samanta
Förderung
- Shiv Nadar Foundation
- Science and Engineering Research Board
- Shiv Nadar University
Zitieren
APA
Munan, S., Mondal, A., Shailja, S., Pati, S., & Samanta, A. (2024). Unique Synthetic Strategy for Probing in Situ Lysosomal NO for Screening Neuroinflammatory Phenotypes against SARS-CoV-2 RNA in Phagocytotic Microglia. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c05981
Vancouver
Munan S, Mondal A, Shailja S, Pati S, Samanta A. Unique Synthetic Strategy for Probing in Situ Lysosomal NO for Screening Neuroinflammatory Phenotypes against SARS-CoV-2 RNA in Phagocytotic Microglia. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.3c05981
BibTeX
@article{Munan2024,
author = {Munan, Subrata and Mondal, Abir and Shailja, Singh and Pati, Soumya and Samanta, Animesh},
title = {Unique Synthetic Strategy for Probing in Situ Lysosomal NO for Screening Neuroinflammatory Phenotypes against SARS-CoV-2 RNA in Phagocytotic Microglia},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.3c05981}
}
EUVIMED